The Canadian company Aurora Cannabis has announced the launch of its first medical hashish product cultivated in Germany in the middle of the rest of restrictions in the German medical hashish market.
Aurora announced this week the launch of its brand, IndiMed, which manufactures medical cannabis products at Aurora’s leading EU-GMP facility in Leuna, Germany.
The first product launched by the IndiMed brand is Island Sweet Skunk, dried flower, sativa, 20% THC, and less than 1 % CBD, which is expected to be available on January 27.
The indimed product is grown according to the guidelines of agricultural and collection practices of the EU-GOOD (GACP) and the EU-GMP (good manufacturing practices). These industry criteria are implemented in the medications destined for importation in the European Union, thus ensuring pharmaceutical quality.
Aurora entered Europe in the mid -2010 and obtained the German Pladanios in 2017 to anchor her presence in the EU. At the end of the 2010, the company expanded to Italy, the Nordic countries and Poland adapting to strict regulations, supplying medicinal cannabis and investing in R&D. The company began to quote on the New York Stock Exchange in 2018, under the ACB symbol.
This announcement comes at a favorable time for the German medical hashish market, which eliminated the hashish of controlled substances drugs and the legalized recreational hashish for non -public use last year.
The medical cannabis markets benefited from this update of the law, since the medical cannabis was flexible.
North American companies have also begun investing in the German market.
Earlier this month, Canada-based cannabis company High Tide entered the German medical cannabis market by acquiring a 51% stake in Frankfurt-based pharmaceutical company Purecan.
A report by cannabis company Bloomwell Group published this month puts into perspective the evolution that has taken place in this industry within the last year alone.
Medicinal hashish is increasingly used to treat health problems, but their access is now less difficult thanks to virtual platforms where patients get the medication under the supervision of a doctor and manufactured according to pharmaceutical standards.
The report identifies a diversification in the strains of medical cannabis dispensed throughout 2024.
Furthermore, Worths have steadily declined, appearing a well-stocked market despite some fluctuations at the start of the year, with the value consistent with the Gram emerging from €9. 27 ($9. 72) in January to €8. 35 ($8. 76) in November. For the first time, a variety indexed at €3. 99 ($4. 19) consistent with Gram.
With the reclassification of medicinal hashish as non -narcotic, which triggered an unprecedented increase in the number of recipes, the number of recipes delivered through pharmacies had increased more than 1,000% until December 2024, rather than in March of the same year , which shows that the regulatory adjustments have caused a replacement in the sea in the media.
One of the other interesting trends found in the report is the increasing demand for high levels of THC in strains. By the end of 2024, strains whose THC content is above 25% constitute nearly a third of all prescriptions, while the average THC concentration was at 23.35%.
Niklas Kouparanis, Co-Founder and CEO of Bloomwell Group, said in a press statement that Germany’s cannabis reforms could serve as a model for other European countries.
“We are at the beginning of a new era,” he said. “Cannabis was widely used for many years. After decades of stigmatization, the German government has inaugurated a replacement in our country that also serves as a progressive policy for other European countries. “
A poll conducted after the legalization of recreational cannabis in December 2024 showed that 59% of Germans support full legalization, marking the first increase in support since the cannabis reform took effect in April last year.
A community. Many voices. Create a free account to share your thoughts.
Our network aims to attach other people through open and thoughtful conversations. We need our readers to share their perspectives and exchange concepts and facts in one space.
To do this, please respect the publishing rules according to the situations of use of our site. We have summarized some of those key regulations. In terms, stay civil.
Your post will be rejected if we notice that it seems to contain:
The user accounts will be blocked if we realize or if users are concerned about:
So, how can you be a power user?
Thank you for reading our Community Standards. Read the full list of posting regulations discovered in our site’s Terms of Use.